![](/img/cover-not-exists.png)
19 WHICH SUBGROUPS OF PATIENTS WITH NEWLY DIAGNOSED TO-4 NO-2 MO PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT (EORTC 30891) ARE AT RISK TO DIE FROM PROSTATE CANCER AND BENEFIT FROM IMMEDIATE ANDROGEN DEPRIVATION?
U.E. Studer, L. Collette, P. Whelan, W. Albrecht, J. Casselman, T. De Reijke, H. Knoenagel, W. Loidl, S. Isorna, S.K. Sundaram, M. DeboisVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-9056(07)60019-0
File:
PDF, 318 KB
english, 2007